Ameritas Investment Partners’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
Ameritas Investment Partners's GOSS Position: Q2 2026 in Review
Ameritas Investment Partners sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 198 shares — an estimated $5.21K sold.
Ameritas Investment Partners first reported a position in GOSS in Q1 2019 and held it in 21 quarters. The position peaked at $60K in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- Ameritas Investment Partners reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 198 Gossamer Bio shares in Q2 2026, an estimated $5.21K.
- Ameritas Investment Partners first reported a position in Gossamer Bio in Q1 2019 and held it in 21 quarters.
- Ameritas Investment Partners's Gossamer Bio position peaked at $60K in Q3 2019.
- 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.